PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y, Toyota M, Kondo Y, Suzuki H, Imai T, Ohe-Toyota M, Maruyama R, Nojima M, Sasaki Y, Sekido Y, Hiratsuka H, Shinomura Y, Imai K, Itoh F, Tokino T.
Watanabe Y, et al. Among authors: kondo y.
Clin Cancer Res. 2007 Aug 15;13(16):4786-94. doi: 10.1158/1078-0432.CCR-07-0305.
Clin Cancer Res. 2007.
PMID: 17699856